Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Controlled, Open-label Trial to Compare the Efficacy, Safety and Tolerability of TMC114/RTV Versus LPV/RTV in Treatment-Experienced HIV-1 Infected Patients
INTERVENTIONAL
Inicio: 1 de abr de 2005
ID: NCT00110877
Terminado
Fase 3
ClinicalTrials.gov
Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV
INTERVENTIONAL
Inicio: 11 de jul de 2013
ID: NCT01866930
Completado
Fase 4
ClinicalTrials.gov
Telmisartan for Treatment of COVID-19 Patients: an Open Label Randomized Trial
INTERVENTIONAL
Inicio: 19 de may de 2020
ID: NCT04355936
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3b, Open Label, Randomized, standard-of Care Control Arm, Multicenter, Superiority Study Evaluating the Efficacy, Safety, and Tolerability of Injectable CAB LA + RPV LA in Viremic Participants Living With HIV-1 (CROWN)
INTERVENTIONAL
Inicio: 2 de dic de 2024
ID: NCT06694805
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double-blind, Multicentre, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Dolutegravir Plus Lamivudine Compared to Dolutegravir Plus Tenofovir/Emtricitabine in HIV-1-infected Treatment-naïve Adults
INTERVENTIONAL
Inicio: 18 de jul de 2016
ID: NCT02831764
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Observer-blind, Controlled, Multi-Center Study to Compare the Safety of One Dose of Novartis Meningococcal ACWY Conjugate Vaccine With That of a Licensed Meningococcal ACWY Polysaccharide Vaccine (Menomune®) Administered to Healthy Children 2 to 10 Years of Age
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00329849
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double Blinded, Placebo Controlled Study of Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
INTERVENTIONAL
Inicio: 1 de ago de 2008
ID: NCT00562510
Completado
Fase 3
ClinicalTrials.gov
Randomized Master Protocol for Immune Modulators for Treating COVID-19
INTERVENTIONAL
Inicio: 15 de oct de 2020
ID: NCT04593940
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Determine the Efficacy and Safety of Inhaled SNG001 for the Treatment of Patients Hospitalised Due to Moderate COVID-19
INTERVENTIONAL
Inicio: 12 de ene de 2021
ID: NCT04732949
Completado
Fase 3
ClinicalTrials.gov
Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission
INTERVENTIONAL
Inicio: 1 de feb de 2004
ID: NCT00099359
Completado
ClinicalTrials.gov
Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis
OBSERVATIONAL
Inicio: 16 de nov de 2022
ID: NCT05641025
Reclutando
Fase 2
ClinicalTrials.gov
A PHASE 2A, 2-PART, OPEN-LABEL, NON-RANDOMIZED, MULTICENTER, SINGLE AND MULTIPLE DOSE TRIAL TO EVALUATE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF AZTREONAM AND AVIBACTAM ± METRONIDAZOLE IN NEONATES AND INFANTS FROM BIRTH TO LESS THAN 9 MONTHS OF AGE WITH SUSPECTED OR CONFIRMED INFECTIONS DUE TO GRAM-NEGATIVE PATHOGENS REQUIRING INTRAVENOUS ANTIBIOTIC TREATMENT
INTERVENTIONAL
Inicio: 25 de sept de 2024
ID: NCT06462235
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
INTERVENTIONAL
Inicio: 7 de mar de 2007
ID: NCT00412893
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Adaptive, Randomized, Double-blinded, Placebo-controlled Phase II/III Trial to Evaluate the Efficacy and Safety of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in Hospitalized Patients With Severe COVID-19
INTERVENTIONAL
Inicio: 27 de mar de 2021
ID: NCT04644185
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ENLIGHTEN-Cirrhosis)
INTERVENTIONAL
Inicio: 24 de may de 2024
ID: NCT06419374
Completado
Fase 4
ClinicalTrials.gov
Strategic Timing of AntiRetroviral Treatment
INTERVENTIONAL
Inicio: 15 de abr de 2009
ID: NCT00867048
Completado
Fase 3
ClinicalTrials.gov
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
INTERVENTIONAL
Inicio: 22 de abr de 2008
ID: NCT00634049
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Phase III Randomized, Double-Blind, Placebo-Controlled, Outpatient Study to Evaluate the Efficacy, Safety, Antiviral Activity of RO7496998 (AT-527) in Patients With Mild or Moderate COVID-19
INTERVENTIONAL
Inicio: 28 de abr de 2021
ID: NCT04889040
Activo, no recluta
Fase 3
ClinicalTrials.gov
Phase 3 Double-blind Multicenter Randomized Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Biktarvy® (Bictegravir/Emtricitabine/Tenofovir Alafenamide) in Virologically Suppressed People With HIV-1
INTERVENTIONAL
Inicio: 25 de mar de 2024
ID: NCT06333808
Completado
Fase 2
ClinicalTrials.gov
Phase II Clinical Trial for the Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease in Adult Patients. Berenice Project
INTERVENTIONAL
Inicio: 21 de abr de 2017
ID: NCT03191162
Anterior
1
...
33
34
35
...
434
Siguiente
Filtros